Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.

Leinonen V, Rauramaa T, Johansson J, Bottelbergs A, Tesseur I, van der Ark P, Pemberton D, Koivisto AM, Jääskeläinen JE, Hiltunen M, Herukka SK, Blennow K, Zetterberg H, Jokinen P, Rokka J, Helin S, Haaparanta-Solin M, Solin O, Okamura N, Kolb HC, Rinne JO.

J Alzheimers Dis. 2018;64(1):171-179. doi: 10.3233/JAD-180071.

PMID:
29865068
2.

Microglial activation, white matter tract damage, and disability in MS.

Rissanen E, Tuisku J, Vahlberg T, Sucksdorff M, Paavilainen T, Parkkola R, Rokka J, Gerhard A, Hinz R, Talbot PS, Rinne JO, Airas L.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 6;5(3):e443. doi: 10.1212/NXI.0000000000000443. eCollection 2018 May.

3.

Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study.

Kemppainen N, Johansson J, Teuho J, Parkkola R, Joutsa J, Ngandu T, Solomon A, Stephen R, Liu Y, Hänninen T, Paajanen T, Laatikainen T, Soininen H, Jula A, Rokka J, Rissanen E, Vahlberg T, Peltoniemi J, Kivipelto M, Rinne JO.

Neurology. 2018 Jan 16;90(3):e206-e213. doi: 10.1212/WNL.0000000000004827. Epub 2017 Dec 20.

PMID:
29263220
4.

Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model.

Snellman A, Rokka J, López-Picón FR, Helin S, Re F, Löyttyniemi E, Pihlaja R, Forloni G, Salmona M, Masserini M, Solin O, Rinne JO, Haaparanta-Solin M.

Neurobiol Aging. 2017 Sep;57:84-94. doi: 10.1016/j.neurobiolaging.2017.05.008. Epub 2017 May 15.

5.

Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.

Sucksdorff M, Rissanen E, Tuisku J, Nuutinen S, Paavilainen T, Rokka J, Rinne J, Airas L.

J Nucl Med. 2017 Oct;58(10):1646-1651. doi: 10.2967/jnumed.116.183020. Epub 2017 Mar 23.

PMID:
28336784
6.

HPLC and TLC methods for analysis of [18F]FDG and its metabolites from biological samples.

Rokka J, Grönroos TJ, Viljanen T, Solin O, Haaparanta-Solin M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Mar 24;1048:140-149. doi: 10.1016/j.jchromb.2017.01.042. Epub 2017 Feb 9.

PMID:
28236580
7.

(18)F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease.

Rokka J, Snellman A, Kaasalainen M, Salonen J, Zona C, La Ferla B, Nicotra F, Re F, Masserini M, Forsback S, Lopez-Picon F, Rinne JO, Haaparanta-Solin M, Solin O.

Eur J Pharm Sci. 2016 Jun 10;88:257-66. doi: 10.1016/j.ejps.2016.03.016. Epub 2016 Mar 16.

PMID:
26993963
8.

Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment.

Kemppainen N, Joutsa J, Johansson J, Scheinin NM, Någren K, Rokka J, Parkkola R, Rinne JO.

J Alzheimers Dis. 2015;48(1):123-33. doi: 10.3233/JAD-150190.

PMID:
26401934
9.

Cardiac remodeling in a new pig model of chronic heart failure: Assessment of left ventricular functional, metabolic, and structural changes using PET, CT, and echocardiography.

Tarkia M, Stark C, Haavisto M, Kentala R, Vähäsilta T, Savunen T, Strandberg M, Hynninen VV, Saunavaara V, Tolvanen T, Teräs M, Rokka J, Pietilä M, Saukko P, Roivainen A, Saraste A, Knuuti J.

J Nucl Cardiol. 2015 Aug;22(4):655-65. doi: 10.1007/s12350-015-0068-9. Epub 2015 Feb 20.

PMID:
25698475
10.

In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.

Rissanen E, Tuisku J, Rokka J, Paavilainen T, Parkkola R, Rinne JO, Airas L.

J Nucl Med. 2014 Jun;55(6):939-44. doi: 10.2967/jnumed.113.131698. Epub 2014 Apr 7.

11.

Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.

Rokka J, Snellman A, Zona C, La Ferla B, Nicotra F, Salmona M, Forloni G, Haaparanta-Solin M, Rinne JO, Solin O.

Bioorg Med Chem. 2014 May 1;22(9):2753-62. doi: 10.1016/j.bmc.2014.03.010. Epub 2014 Mar 18.

PMID:
24702859
12.

Cortical ¹¹C-PIB uptake is associated with age, APOE genotype, and gender in "healthy aging".

Scheinin NM, Wikman K, Jula A, Perola M, Vahlberg T, Rokka J, Någren K, Viitanen M, Rinne JO.

J Alzheimers Dis. 2014;41(1):193-202. doi: 10.3233/JAD-132783.

PMID:
24603945
13.

Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180.

Dickens AM, Vainio S, Marjamäki P, Johansson J, Lehtiniemi P, Rokka J, Rinne J, Solin O, Haaparanta-Solin M, Jones PA, Trigg W, Anthony DC, Airas L.

J Nucl Med. 2014 Mar;55(3):466-72. doi: 10.2967/jnumed.113.125625. Epub 2014 Feb 10.

14.

In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [(18)F]flutemetamol.

Snellman A, Rokka J, López-Picón FR, Eskola O, Salmona M, Forloni G, Scheinin M, Solin O, Rinne JO, Haaparanta-Solin M.

EJNMMI Res. 2014 Aug 1;4:37. doi: 10.1186/s13550-014-0037-3. eCollection 2014.

15.

19F/18F exchange synthesis for a novel [18F]S1P3-radiopharmaceutical.

Rokka J, Federico C, Jurttila J, Snellman A, Haaparanta M, Rinne JO, Solin O.

J Labelled Comp Radiopharm. 2013 Jun 30;56(8):385-91. doi: 10.1002/jlcr.3055. Epub 2013 Jun 5.

PMID:
24285478
16.

Five-year follow-up of 11C-PIB uptake in Alzheimer's disease and MCI.

Kemppainen NM, Scheinin NM, Koivunen J, Johansson J, Toivonen JT, Någren K, Rokka J, Karrasch M, Parkkola R, Rinne JO.

Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):283-9. doi: 10.1007/s00259-013-2562-0. Epub 2013 Sep 27.

PMID:
24072346
17.

Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.

Snellman A, López-Picón FR, Rokka J, Salmona M, Forloni G, Scheinin M, Solin O, Rinne JO, Haaparanta-Solin M.

J Nucl Med. 2013 Aug;54(8):1434-41. doi: 10.2967/jnumed.112.110163. Epub 2013 Jul 5.

18.

Pharmacokinetics of [¹⁸F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.

Snellman A, Rokka J, Lopez-Picon FR, Eskola O, Wilson I, Farrar G, Scheinin M, Solin O, Rinne JO, Haaparanta-Solin M.

Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1784-95. doi: 10.1007/s00259-012-2178-9. Epub 2012 Jul 17.

PMID:
22801729
19.

[18F]CFT synthesis and binding to monoamine transporters in rats.

Forsback S, Marjamäki P, Eskola O, Bergman J, Rokka J, Grönroos T, Haaparanta M, Solin O.

EJNMMI Res. 2012 Jan 25;2(1):3. doi: 10.1186/2191-219X-2-3.

20.

Early detection of Alzheimer disease: ¹¹C-PiB PET in twins discordant for cognitive impairment.

Scheinin NM, Aalto S, Kaprio J, Koskenvuo M, Räihä I, Rokka J, Hinkka-Yli-Salomäki S, Rinne JO.

Neurology. 2011 Aug 2;77(5):453-60. doi: 10.1212/WNL.0b013e318225118e. Epub 2011 Jun 22.

PMID:
21700581
21.

[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.

Jokinen P, Scheinin N, Aalto S, Någren K, Savisto N, Parkkola R, Rokka J, Haaparanta M, Röyttä M, Rinne JO.

Parkinsonism Relat Disord. 2010 Dec;16(10):666-70. doi: 10.1016/j.parkreldis.2010.08.021. Epub 2010 Sep 25.

PMID:
20870446
22.

PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease.

Koivunen J, Verkkoniemi A, Aalto S, Paetau A, Ahonen JP, Viitanen M, Någren K, Rokka J, Haaparanta M, Kalimo H, Rinne JO.

Brain. 2008 Jul;131(Pt 7):1845-53. doi: 10.1093/brain/awn107. Epub 2008 Jun 25.

PMID:
18583368
23.

Autoradiographic characterization of alpha(2C)-adrenoceptors in the human striatum.

Fagerholm V, Rokka J, Nyman L, Sallinen J, Tiihonen J, Tupala E, Haaparanta M, Hietala J.

Synapse. 2008 Jul;62(7):508-15. doi: 10.1002/syn.20520.

PMID:
18435421

Supplemental Content

Support Center